In esophageal squamous cell carcinoma (ESCC), IL-17 promotes humoral immunity mediated by B cells by inducing chemokines and enhances the tumor-killing ability of B cells indirectly and directly by stimulating the production of IgG and granzyme B (166). This evidence concerns the gene GZMB and esophageal squamous cell carcinoma.